![](https://investorshub.advfn.com/uicon/19649.png?cb=1607617291)
Wednesday, September 09, 2020 12:35:16 PM
For NeuroRX to say..."We're committed to addressing this unmet need as quickly as possible."
This tells me that they have a viable product (they have the data and the trials went well), they are planning on bringing it to the market (manufacturing in place or being developed) and they are moving forward as quickly as possible (they are waiting for the FDA approval process to play out).
The ball is likely not in their court at the moment so they are waiting like all of us.
---
follow up reply: @BobbyLeeSwagger might not be a wise move to "pressure" the FDA by releasing any data.. i appreciate that they do this very professional. I rather see an approval at the end of a no-news period then news every day and no approval in the end. they are not just pumping their stock like our competition, rlftf does serios science, how it should be..
~ Money Making Money ~
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM